Pulmonary Medical Division

The Duke Fellowship Training Programs in Pulmonary and Critical Care Medicine produce outstanding physicians who are fully prepared to pursue careers in academic medicine.

Our combined Pulmonary and Critical Care Medicine fellowship program is a three-year program. Upon completion of training, fellows are eligible for dual certification in pulmonary and critical care medicine. The American Board of Internal Medicine requires a minimum 18 months of clinical training for board certification in both of these disciplines. All fellows in our combined program engage in scholarly activity and receive robust mentorship from our world-renowned faculty. We offer a fourth year of fellowship for trainees seeking advanced research training.

Our combined fellowship program accepts 5 fellows each year.

In their words

See why our fellows chose Duke, the strengths of the Duke PCCM Fellowship Program, and more.

As you explore our programs, please visit our about Duke and Durham page to see all that our city has to offer. We also encourage you to check out our 48 hours in Durham list, which highlights some of our favorite things to do and places to visit in the area.

Latest News

Eight from Medicine selected for Duke Clinical Leadership Program

Duke Health has announced a new class of the Duke Clinical Leadership Program (DCLP), including eight faculty from the Department of Medicine. The 26 clinicians in the 2018 class will join the ranks of the 169 fellows who completed the DCLP program during its first seven years. 

Taking the lung apart cell by cell, to mend it

The photograph of blue, pink and neon-green globes that Christina Barkauskas, MD, keeps on her desk inside the Nanaline Duke Research Building looks like a string of glowing holiday lights. That is, until she decodes it.

Produced with a confocal microscope, the image is evidence of new insight into how some lung tissue repairs itself. It captures type 2 epithelial cells within alveoli functioning like stem or progenitor cells by giving rise to type 1 epithelial cells, which contribute to tissue repair.  

For Dr. Barkauskas, this is not knowledge for knowledge’s sake. It’s data needed to better serve  patients with often-lethal idiopathic pulmonary fibrosis.

New PDC members, August 2017

The following providers in the Department of Medicine joined the Private Diagnostic Clinic (PDC) in July, as reported by the PDC Physician Integration Office.

Find clinic information and appointment phone numbers for each of these PDC members on DukeHealth.org.

Leadership Q&A with Scott Palmer, MD, MHS

Scott Palmer, MD, MHS, has turned his love for research and discovery into making a lasting impact on pulmonary patients across the country. In this Q&A, he elaborates on his path to being a pulmonary researcher and its life-changing experiences, and his insights on why medical research is vital for progression in medicine.